TYO:4594

BrightPath Biotherapeutics Co.,Ltd. Stock Insider Trading

Tokyo Stock Exchange > Healthcare > Biotechnology

JP¥55.00

+0 (+0%)

At Close: Jun 21, 2024

BrightPath Biotherapeutics Co.,Ltd. Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 4594.T shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About BrightPath Biotherapeutics Co.,Ltd.

BrightPath Biotherapeutics Co., Ltd. develops cancer immunotherapy drugs. The company is developing GRN-1201 that is in Phase II clinical study for the treatment of non-small cell lung cancer, as well as in Phase I clinical study to treat melanoma. It also develops BP1101, a neoantigen vaccine; BP1209, a platform of personalized neoantigen cancer vaccines; and BP1401, an agonist for toll-like receptor 9. In addition, the company offers induced pl... 4594.T Profile

Golden Star

Ticker	Date	Change	Price
V	Jun 18	0.585%	$273.62
EPD	Jun 18	0.95%	$28.30
USFD	Jun 18	0.565%	$53.14
INTC	Jun 18	1.50%	$30.63
UFPT	Jun 18	3.45%	$253.79
^DJI	Jun 18	0.81%	38,834.86 points
BR	Jun 17	1.59%	$197.65
SARK	Jun 17	1.98%	$30.34
RGA	Jun 17	1.62%	$203.90
MA	Jun 17	1.50%	$448.11

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In